Skip to main content
. 2019 Jan 22;20:44. doi: 10.1186/s12859-019-2608-9

Fig. 12.

Fig. 12

Comparisons between predicted and observed IC50 values for BRAF mutant and wild-type cell lines to three MEK1/2-inhibitors. (a) Consistence between the predicted response values by CDCN model I and the observed response values. (b) Consistence between the predicted response values by CDCN model II and the observed response values